|Security||OGRMF / Organigram Holdings, Inc. (68620P101)|
|Industry||Cannabis and Medical Marijuana Dispensaries|
|Institutional Value||$ 200,000 USD|
Institutional Stock Ownership and Shareholders
Organigram Holdings, Inc. (OTC:OGRMF) has 5 institutional investors and shareholders that have
filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38,035 shares.
Largest shareholders include
Rothschild Investment Corp /il, Intercontinental Wealth Advisors, Llc, AlphaMark Advisors, LLC, Horrell Capital Management, Inc., and CENTRAL TRUST Co.
Organigram Holdings, Inc. (OTC:OGRMF) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.
|Horrell Capital Management, Inc.||1,000||5|
|ROTHSCHILD INVESTMENT CORP /IL||24,100||129|
|Intercontinental Wealth Advisors, Llc||11,366||60|
|AlphaMark Advisors, LLC||1,469||6|
|CENTRAL TRUST Co||100||0|
2017-12-18 - Asif
Organigram Holdings is licensed as a Licensed Producer of medical marijuana, including dried cannabis and cannabis oil, under the ACMPR. Pursuant to its license, the Company is permitted to possess, produce, sell, provide, ship, deliver, transport and destroy medical marijuana, marijuana plants (including plants and seeds) and cannabis oil, in conformity with the ACMPR, and made its first shipment of medical marijuana to registered patients in September 2014. As at the date hereof, the Company has one of 32 licenses to produce and sell medical marijuana and one of 20 licenses to produce and sell cannabis oil under the ACMPR. The Company has the only license to produce and sell both medical marijuana and cannabis oil in Atlantic Canada. Moreover, management believes that the Company benefits from a number of competitive advantages which will allow it to be strategically positioned for future potential developments in the industry. The Company has entered into agreements with sever...
Related News Stories
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com (9-2)
Your license and viewing of our content is subject to the disclosures contained after this article. (5-4)
Canada is set to flip the switch for legal sale of recreational marijuana in just a few weeks. (13-2)
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com (8-1)
The company focuses on the production of medical cannabis in Canada and Europe, and the supply of high-quality cannabis products. (10-1)
as of ET